Skip to main content

Find Clinical Trials

Home
Conditions
Thyroid Cancer, Papillary

Clinical trial condition

Thyroid Cancer, Papillary

Explore clinical trials studying Thyroid Cancer, Papillary. Study availability and eligibility vary by location and protocol.

139 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Thyroid Cancer, Papillary trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00068497

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

NGR-TNF in Treating Patients With Advanced Solid Tumors

NCT00098943

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +60 more
Locations: University Medical Center Hamburg - Eppendorf Hamburg, Germany

Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands

View Trial Details

Completed

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

NCT00062348

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +46 more
Locations: Universitaetsklinikum Essen Essen, Germany

View Trial Details

Completed

Prophylactic Central Neck Dissection for Papillary Thyroid Cancer

NCT01510002

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: Jagiellonian Univerity, Medical College, 3rd Department of General Surgery Krakow, Malopolska, Poland

View Trial Details

Completed

Study of XL281 in Adults With Solid Tumors

NCT00451880

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Neoplasms, +40 more
Locations: Premiere Oncology of Arizona Scottsdale, Arizona, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

NCT00667641

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +67 more
Locations: Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Terminated

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

NCT05575440

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +14 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details